M3 (MEX:2413N) ROCE %: 8.90% (As of Mar. 2026)

What is M3 ROCE %?

M3 MEX:2413N 86 ROCE % is 8.90% as of Mar. 2026. GuruFocus rates MEX:2413N with a GF Score™ of 86/100 and a GF Value™ of MXN261.79. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. M3's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.90%.

M3 (MEX:2413N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

M3 ROCE % Related Terms

M3 ROCE % Historical Data

* Premium members only.

The historical data trend for M3's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3 ROCE % Chart

M3 Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

35.76

21.23

16.51

15.57

13.55

M3 Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															10.06	15.92	12.94	20.15	8.90

86GF Score

M3 Inc MEX:2413N

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

M3 ROCE % Calculation

M3's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	8783.007	/	( ( (79844.126 - 11270.171)	+	(72433.673 - 11364.794) )	/ 2 )
	=	8783.007	/	( (68573.955	+	61068.879)	/ 2 )
	=	8783.007	/	64821.417
	=	13.55 %

M3's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	5547.448	/	( ( (74412.512 - 10876.637)	+	(72433.673 - 11364.794) )	/ 2 )
	=	5547.448	/	( ( 63535.875	+	61068.879 )	/ 2 )
	=	5547.448	/	62302.377
	=	8.90 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 8.90% mean?

M3 (MEX:2413N) has a ROCE % of 8.90% as of Mar. 2026.

Is M3's ROCE % too high?

M3's current ROCE % is 8.90%. The Healthcare Providers & Services industry median ROCE % is 6.41. M3's value of 8.90% is 38.8% above this industry median. Overall, M3 has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.

How does M3's ROCE % compare to VEEV and BTSG?

M3's ROCE % of 8.90% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. M3's value of 8.90% is 38.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current ROCE % of 8.90% is 38.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current ROCE % is 8.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is M3 stock overvalued right now?

M3 (MEX:2413N) has a current ROCE % of 8.90%. The stock's GF Value™ is MXN261.79, compared to a current price of MXN183.50 — trading 29.9% below its estimated fair value. The current ROCE % is 8.90% and 38.8% above the Healthcare Providers & Services industry median of 6.41. M3's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For M3 (MEX:2413N), the current ROCE % is 8.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (MEX:2413N) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of MXN183.50 is trading 29.9% below its estimated GF Value™ of MXN261.79.

Key valuation signals for MEX:2413N:

ROCE %: 8.90%
GF Value™: MXN261.79 vs. price of MXN183.50 (29.9% below fair value)
GF Score™: 86/100 with 3 warning signs
Industry Position: 38.8% above the Healthcare Providers & Services median

No single metric tells the full story. See the MEX:2413N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M3 Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies TSE:4483 TSE:2175 TSE:4480 TSE:3733 TSE:6078 TSE:4820 TSE:9438 TSE:5592 TSE:5038 TSE:4320 VEEV BTSG ASX:PME TEM HQY HKSE:02228 HNGE DOCS WAY TXG

Other Exchanges MTHRY:USA 2413:Japan 4YC:Germany

Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052

Website https://corporate.m3.com

M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.

86GF Score

Get the complete analysis for MEX:2413N

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN183.50

Price

MXN261.79

GF Value

View MEX:2413N Analysis

See ROCE % data for all stocks →